Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov:144:110254.
doi: 10.1016/j.mehy.2020.110254. Epub 2020 Sep 10.

Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis

Meenu Mehta  1 , Parteek Prasher  2 , Mousmee Sharma  3 , Madhur D Shastri  4 , Navneet Khurana  5 , Manish Vyas  5 , Harish Dureja  6 , Gaurav Gupta  7 , Krishnan Anand  8 , Saurabh Satija  1 , Dinesh Kumar Chellappan  9 , Kamal Dua  10
Affiliations

Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis

Meenu Mehta et al. Med Hypotheses. 2020 Nov.

Abstract

The highly contagious coronavirus, which had already affected more than 2 million people in 210 countries, triggered a colossal economic crisis consequently resulting from measures adopted by various goverments to limit transmission. This has placed the lives of many people infected worldwide at great risk. Currently there are no established or validated treatments for COVID-19, that is approved worldwide. Nanocarriers may offer a wide range of applications that could be developed into risk-free approaches for successful therapeutic strategies that may lead to immunisation against the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) which is the primary causative organism that had led to the current COVID-19 pandemic. We address existing as well as emerging therapeutic and prophylactic approaches that may enable us to effectively combat this pandemic, and also may help to identify the key areas where nano-scientists can step in.

Keywords: COVID-19; Drug delivery; Nanoparticles.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Advanced therapeutics delivery strategies in targeting COVID-19.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Singh Y, Gupta G, Satija S, Negi P, Chellappan DK, Dua KJDT. RAAS blockers in hypertension posing a higher risk towards the COVID‐19; 2020. - PMC - PubMed
    1. Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, Veesler DJC. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein; 2020. - PMC - PubMed
    1. Schoeman D, Fielding BCJVj. Coronavirus envelope protein: current knowledge 16;2019:1–22. - PMC - PubMed
    1. Zumla A, Chan JF, Azhar EI, Hui DS, Yuen K-YJNrDd. Coronaviruses—drug discovery and therapeutic options 15;2016:327–347. - PMC - PubMed
    1. Letko M, Marzi A, Munster VJNm. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses 5;2020:562–569. - PMC - PubMed